What the NEDA reveals about Real World HF Outcomes in Australia
What the NEDA reveals about Real World HF Outcomes in Australia

23 July 2026
07:00 PM - 08:00 PM
Place
Virtual
2026-07-23T19:00:00 2026-07-23T20:00:00 New RWE: What NEDA Reveals About Heart Failure Outcomes For Australians Virtual Novartis One CMS [email protected] Add to my Calendar

Join Professors Stewart, Playford and Strange as they discuss the latest findings from the National Echo Database Australia (NEDA), recently presented at ESC Heart Failure 2026

 

Using real-world Australian data, the faculty will explore heart failure treatment patterns, patient outcomes, and the implications for clinical practice, including the importance of optimising guideline-directed medical therapy (GDMT).1

We encourage you to join this informative discussion as we reflect upon the implications for local clinical practice. Please secure your spot by registering for the event.

Hear from your speakers

  • Agenda
  • 07:00 07:05 PM
    Welcome and introductions
    Prof. John Atherton
    07:05 07:15 PM
    Big Data in CVD: An Australian perspective
    Prof. Geoff Strange
    07:15 07:25 PM
    The impact of GDMT on HF outcomes - Insights from NEDA
    Prof. Simon Stewart
    07:25 07:35 PM
    Implications for Australian clinical practice
    Prof. David Playford
    07:35 07:55 PM
    Q&A
    Prof. John Atherton, Prof. David Playford, Prof. Geoff Strange, Prof. Simon Stewart
    07:55 08:00 PM
    Closing remarks
    Prof. John Atherton
Speakers
Professor David Playford
prof
David
Playford
MBBS PhD FRACP FCSANZ FESC FACC, Professor & Head of Cardiology Teaching and Research, University of Notre Dame; Cardiac Imaging Cardiologist, Advara Heart Care. Founder, Director & Chief Investigator of NEDA; Chair of CSANZ in WA
Professor Simon Stewart
prof
Simon
Stewart
PhD, DMSc, FESC, FHFA, Head of Cardiovascular Health Research, Institute of Health Research, University of Notre Dame, Director of Research, National Echo Database Australia
Professor Geoff Strange
prof
Geoff
Strange
Professor, Faculty of Medicine and Health, University of Sydney and School of Medicine, University of Notre Dame, Australia; Senior Academic Lead, Heart Research Institute Sydney; member, Cardiology Research Team Royal Prince Alfred Hospital, Sydney; ,
Creator, Director and Chief Investigator, NEDA
Professor John Atherton
prof
John
Atherton
Pre-eminent Staff Specialist & Director of Cardiology, Royal Brisbane and Women’s Hospital; Professor, University of Queensland. ESC Heart Failure Association Ambassador (2023-2024). Chair, 2018 NHFA/CSANZ Heart Failure Guidelines.

Secure your place!

 

Register below to join us for this important live event.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

References

  1. Stewart S. Trends in heart failure treatment & outcome: Insights from NEDA. Oral presentation. ESC Heart Failure, May 2026.

PBS Information: Authority required (STREAMLINED) for chronic heart failure. Refer to PBS Schedule for full Authority Information.

Please review Product Information before prescribing. 

For ENTRESTO® Product Information, please click here. 

This content is intended for Australian healthcare professionals.

Abbreviations: CVD, cardiovascular disease, HF, heart failure, GDMT, guideline-directed medical therapy, NEDA, National Echo Database Australia.

Tags

  • Cardiology
  • ENTRESTO® (sacubitril/valsartan)
AU-30839 June 2026